Markov Biosciences Analysis: $300K Raised

Markov Biosciences specializes in interpretable biological simulators that accelerate early-stage therapeutics discovery. Their unique approach combines machine learning with extensive biological data to create virtual cell models. This innovation enables research teams to efficiently identify therapeutics for clinical advancement.

Accelerate the design of wet-lab experiments; Analyze biological data through interpretable models; Simulate complex biological systems in silico; Optimize therapeutic discovery processes; Conduct virtual experiments with diverse modalities